• Journal of Investigative Oncology
  • Associate Editor

    Ahmad R. Safa


    Dr. Ahmad R. Safa is working as a Professor of Cancer Research at Indiana University. He is also working as the Professor of Pharmacology and Toxicology at Indiana University. Dr. Ahmad R. Safa is also a Co-Director for Therapeutic Validation core (TVC) at Indiana University Simon Cancer Center, USA. His research focuses on pancreatic cancer and lung cancers.
  • Associate Editor

    Toshihide Tanaka

    Department of Neurosurgery, Jikei University School of Medicine, Kashiwa Hospital, Chiba, Japan.

    Dr. Toshihide Tanaka is Assistant Professor and Chief Medical Officer of Jikei University School of Medicine. Major research interest of Dr. Tanaka is regarding Gene Therapy for Brain Tumors, Tumor Angiogenesis, Apoptosis, Cerbral Ischemia and Vascular Biology, Minimally Invasive Image-Guided Neurosurgery & Brain Tumor Surgery utilizing Intraoperative MRI. Dr. Tanaka has authored about 100 articles published in peer-reviewed medical and scientific journals, and has given more than 300 presentations in medical and scientific conferences in Japan and United States. Dr. Tanaka is a member of the Japan Neurosurgical Society, American Association of Neurological Surgeons, Japan Society for Neuro-Oncology, and Japan Cancer Society. He is also an active member of American Association for Cancer Research.
  • Associate Editor

    Dario Carlo Angelo Baratti

    Italian National Cancer Institute, Milano (Italy).

    Dario Baratti, MD is a member of the Advisory Board of the Scientific Direction of the National Cancer Institute in Milan. He has a publication track record of 139 indexed papersan H-index of 46 (Scopus). Dario Baratti is the general Secretery of the Italian Society of local-regional Oncological Therapies and member of the Peritoneal Surface Malignancies Onco-team of the Italia Society of Surgical Oncology. He was an official member of the invited faculty at the following Advanced Courses of the European Society of Surgical Oncology (ESSO). Major research interest of Dr. Dario Baratti is peritoneal malignancies, colorectal cancer.
  • Associate Editor

    Yasser E. Elborai

    Associate Professor and Consultant of Pediatric Oncology and Stem Cell Transplant

    Dr. Yasser E. Elborai is currently working as an Associate Professor of Pediatric Hematology/Oncology and Hematopoietic Stem Cell Transplant (HSCT) at National Cancer Institute (NCI), Cairo University, Egypt. He is also working as Consultant of Pediatric Oncology and Hematopoietic Stem Cell Transplant (HSCT) at Prince Sultan Military Medical City (PSMMC) Riyadh, Saudi Arabia. Major research interest of Dr. Yasser E. Elborai is regarding  Pediatric Hematology and Oncology.
  • Associate Editor

    Zhongliang Ma

    Associate Professor at Laboratory for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, China.

    Dr. Zhongliang Ma is currently waorking as Associate Professor at Laboratory for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai, China. He received his Ph.D from Institute of Microbiology, Chinese Academy of Science (2003). He worked at China Pharmaceutical University (1996-1999) and as postdoc in 2003-2006. Now he works at School of Life Sciences and he is the Member of Shanghai Society of Microbiology. In 2013-2014, he worked in MD Anderson Cancer Center in USA as senior visiting scholar.
  • Associate Editor

    Prof. Yuseok Moon

    Professor, Lab. of Mucosal Exposome & Biomodulation, Department of Biomedical Sciences, Pusan National University.

    Prof. Yuseok Moon is a Professor at the Laboratory of Mucosal Exposome and Biomodulation, Department of Biomedical Sciences, Pusan National University, South Korea. He is presently Fellow ATS (Academy of Toxicological Sciences), USA. His main research focuses on Food toxicology and safety, Toxicity and Monitoring of Foodborne mycotoxins (ribotoxins), Pathogenesis of foodborne enteropathogenic bacteria, Mucosaltoxicity and inflammation, Gut microbiota, Colon cancer and Inflammatory bowel disease.
  • Associate Editor

    Osamu Tanaka

    Chief Professor, Department of Radiation Oncology, Asahi University Hospital, Japan.

    Osamu Tanaka currently works as Chief Professor of Radiation Oncology at the Department of Radiation Oncology, Asahi University Hospital, Japan. Osamu does research in Radiology, Oncology and Radiotherapy. He possess more than 16 years of progressive experience in the Radiation Oncology field. His professional history includes positions such as Radiation Oncologist at Asahi University Hospital as well as Radiation Oncology at Gifu University Hospital.
  • Editorial Panel

    Kimberly A. Greer

    Assistant Professor

    Dr. Kimberly A. Greer is an experienced research Geneticist who has directed Microbiology divisions for my academic tenure. She is an avid Program Manager who has managed numerous government funded grant programs covering the fields of molecular diagnostics, genetics, and cell biology. Her management experience has been demonstrated in the industry (Eli Lilly and Co.), government (USAFRL), and academia (TAMU, IUE, PVAMU). She enjoys being part of the active investigative team bringing experimental results to fruition in a timely manner while cost cutting the process.
  • Editorial Panel

    J. Ignacio Tello

    Associate Professor

    Dr. J. Ignacio Tello is an Associate Professor at the Department of Applied Mathematics, Technical University of Madrid. His main research focuses on Mathematical modeling, Mathematical models of Cancer stem cells, Mathematical models of Bone marrow transplantation, Mathematical biology.
  • Editorial Panel

    Mohammed Abdullah Alshawsh

    Associate Professor

    Dr. Mohammed Alshawsh is currently working as Associate Professor at Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. He obtained his Ph.D. from Faculty of Medicine, the University of Malaya in 2012. After his one year postdoc at the University of Malaya, he joined Department of Pharmacology, the University of Malaya in 2013. Since then he has been doing preclinical research in the area of metabolic syndrome, cancer, and safety pharmacology. His current field of research interest mainly focuses on the pharmacological and toxicological evaluation of natural products for the treatment of colorectal cancer, obesity, diabetes, and fatty liver diseases using in vivo (animal models) and in vitro (cell culture) studies and investigating the gene expression profiling to unravel the underlying molecular mechanisms involved. He is also doing safety and toxicology studies in particular acute, subacute, and chronic toxicities, genotoxicity, teratogenicity, and postnatal developmental toxicity. Dr. Alshawsh is a member of Italo-Latin American Society of Ethnomedicine, Malaysian Society of Pharmacology and Physiology and American Society for Microbiology. He serves as a reviewer for several international journals, such as BMC Complementary Alternative Medicine, European Journal of Clinical Investigation, Journal of European Food Research and Technology, Phytotherapy Research and International Journal for Integrative Biology. Currently, he is supervising 8 Ph.D. students and 1 Master student. He has published over 25 papers in peer-reviewed journals and has given over 15 invited and plenary lectures at international conferences. He has obtained several research grants, such as UMRG, PPP and FRGS and has an h-index of 9 and citations of more than 193 (Scopus) (h-index of 8 and citations of more than 125 Web of Science).
  • Editorial Panel

    Lingzhi WANG

    Assistant Professor

    Dr. Wang is an Assistant Professor in the Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore (NUS). He also has been working as a Senior Research Scientist at the Cancer Science Institute of Singapore since 2011. Dr. Wang obtained his M.Med. in Medicinal Chemistry from Chongqing Medical University in 1993. He continued his postgraduate studies in NUS and obtained his M.Sc. in Pharmacy and Ph.D. in Pharmacology in 2003 and 2008, respectively. Dr. Wang received the Medical Research Scientist Award from the National Medical Research Council (NMRC Singapore) in 2005, and the Ph.D. Graduate Research Excellence Award from the American Association of Pharmaceutical Scientists (AAPS) at its Annual Meeting in 2008 (USA). To date, he is the author of over 70 research papers, including articles in Cell, Journal of Clinical Oncology, Clinical Cancer Research, Trends in Pharmacology, and Trends in Biotechnology etc.
  • Editorial Panel

    Luca Saragoni

    Medical Pathologist

    Dr. Saragoni, former national coordinator of the Italian Pathologists Group, within the Italian Society of Anatomy of Pathology, in the study and research of digestive diseases, is the author of 112 scientific publications in national and international journals. He was employed as a pathologist at the General Hospital G.B.Morgagni-L. Pierantoni of Forlì (Italy) since 1993. He deals with topics related to histopathology, preventive and diagnostic cytology, oncological screening, immunocytochemistry, electronic microscopy, telepathology, autopsies, legal medicine.
  • Editorial Panel

    Susanna Guerrini

    Department of Medicine, Surgery and NeuroscienceSiena, Italy.

    Dr. Susanna Guerrini is an expert in the field of Radiology, graduated cum laude in 2011 at the University of Siena, she partecipated to many publications in the fields of oncology, immunology, reumatology and pneumology. She co-help in trained radiologists with daily activity for diagnostic imaging (CT and MRI body imaging, Perfusion CT and MRI, Dual Energy CT, Oncologic imaging, Diagnostic Imaging in Rheumatology Abdominal Imaging, Thoracic imaging) and teaching activity. She has also been part of many Scientific Society with national and international interest (SIRM, ESR, ESOI, ESGAR, GIRCG). 
  • Editorial Panel

    Mosab Shetiwy

    Associate Professor of Surgical Oncology, Oncology Center, Mansoura University (OCMU), Egypt.

    Dr. Mosab Shetiwy is an Associate Professor of Surgical Oncology and Surgical Oncology Consultant at Oncology Center, Mansoura University (OCMU), Egypt. Major research interest of Dr. Mosab Shetiwy is regarding Laparoscopic Surgery, Surgery Oncology, Surgical Oncology General Surgery, Colorectal Surgery Abdominal Surgery, Minimally Invasive Surgery, Gastrointestinal Surgery, Gastrointestinal Diseases. He is having active scientific memberships at Intercollegiate Member of Royal College of Surgeons of England, European Society of Surgical Oncology, Egyptian Society of Surgery, etc.
  • Editorial Panel

    Nicolo Fabbri

    Sant’Anna Hospital, University of Ferrara, Ferrara, Italy.

    Dr. Fabbri graduated at Ferrara University (Italy) in 2012 with research on the laparoscopic treatment of gastrointestinal stromal tumors and became General Surgeon in 2019 with a research on Intraoperative radiotherapy (IOERT). His main researches are focused on general and thoracic surgery. Notably, he published literature reviews on gastrointestinal tumors, an overview of breast cancer and a pilot study on perianal fistula.He manages a website on medicine "www.surgicalitaly.com" based on researches from his Department.In 2017 he won the “Barioni Prize” by the Order of Physicians of Ferrara with research on new therapy of perianal fistulas, published in 2019. In 2018 he attended the National Cancer Center of Aviano (Italy) for training on breast surgery.He was also graduated in echography (at the Italian Society of Ultrasound in Medicine) and Trauma management (by the American College of Surgeon). In 2019 he started biostatistics at the University of Padua (Italy).
  • Editorial Panel

    Zhitao Dai

    Research Fellow and Medical Physicist, Cancer Hospital, Chinese Academy of Medical Sciences, China.

    Dr. Zhitao Dai is currently working as a Research Fellow and Medical Physicist at Cancer Hospital, Chinese Academy of Medical Sciences, China. He has done with Post doctorialship from School of physics and technology, Wuhan University, China. His main research interests are Beam transport and dosimetry monitoring in proton therapy; Nuclear reactions in proton therapy; Dosimetry and radiobiology of SBRT.
  • Editorial Panel

    Mariangela De Robertis

    Research Fellow at National Research Council - Institute of Biomembrane, Bioenergetics and Molecular
    Biotechnology (CNR-IBIOM), Bari, Italy.

    Dr. Mariangela De Robertis is currently working as Research Fellow at National Research Council - Institute of Biomembrane, Bioenergetics and Molecular Biotechnology (CNR-IBIOM), Bari, Italy, and Professor in charge in “Applied Immunology”, Department of Biosciences, Biotechnology and Biopharmaceutics, University of Bari, Italy. Dr De Robertis obtained her Ph.D in Experimental Oncology in 2010 from the University of Foggia, operating with the University Campus Bio-Medico of Rome. Then she worked as visiting scientist to the Center for Applied Medical Research (CIMA), University of Navarra, Pamplona (Spain) (2010) and as Research Fellow at the University Campus Bio-Medico of Rome (2011-2016). Her main research interests focus on translational oncology and molecular pathology, epigenetic modifications in cancer stem cells, colorectal cancer, cancer immunotherapy.
  • Editorial Panel

    Victor-Vlad Costan

    Associate Professor, Department of Oral and Maxillo-Facial Surgery ” St Spiridon ” University Accident Hospital – Iași.

    Dr. Victor-Vlad Costan is currently waorking as Associate Professor, Department of Oral and Maxillo-Facial Surgery ” St Spiridon ” University Accident Hospital – Iași, Romania. He is also working as a Lecturer at Faculty of Dentistry, Grigore T. Popa Iasi University of Medicine and Pharmacy, Iasi, Romania. He is the Member of the following societies: Romanian Society of Maxillofacial Surgery, Romanian Society for Reconstructive Microsurgery, European Association of Cranio Maxillo Facial Surgeons, International Association of Oral and Maxillo Facial Surgeons. His main research interests are Oral Diseases, Treatment, Diagnosis, Oral Surgery, Surgery, Periodontics and Oral Pathology, Cell Culture, Oncology, Tumors, Computed Tomography.
  • Editorial Panel

    Rodrigo da Silva Ferreira

    Temporary Professor, State University of Minas Gerais, Brazil.

    Dr, Rodrigo da Silva Ferreira is currently working as a Temporary Professor at State University of Minas Gerais, Brazil. He did his PhD in Science in Molecular Biology from Federal University of São Paulo, UNIFESP, São Paulo, Brazil with Sandwich Doctorate in National Cancer Institute (Advisor: Alexander Wlodawer). He also completed his post doctorate from Federal University of São Paulo, UNIFESP, Sao Paulo, Brazil. He is having expertise in the field of Biochemistry, Molecular Biophysics and Nanotechnology.

Recommended Articles

Our articles most useful